Stimuli-Responsive Drug Release Materials — PatSnap Eureka
Stimuli-Responsive Drug Release Materials: Technology Landscape 2026
Smart drug delivery systems that respond to pH, temperature, redox gradients, and light are reshaping pharmaceutical R&D. Explore the patent and literature landscape powering this field — and discover how AI-driven intelligence accelerates your research.
Four Primary Stimuli Modalities in Drug Release Research
Stimuli-responsive drug release materials exploit specific physiological or external triggers to achieve targeted, controlled payload delivery. Each modality maps to distinct WIPO IPC classifications and research bodies.
pH-Responsive Carriers
pH-responsive materials exploit the acidic tumour microenvironment to trigger drug release selectively at disease sites. These systems remain stable at physiological pH 7.4 and release payloads under the acidic conditions characteristic of tumour tissue, endosomes, and lysosomes.
Tumour microenvironment targetingThermo-Responsive Systems
Thermo-responsive drug carriers release therapeutic payloads above physiological temperature thresholds. These materials undergo conformational or phase transitions at defined temperatures, enabling triggered release in hyperthermic tumour environments or via external thermal stimulation.
Above physiological temperature thresholdRedox-Responsive Materials
Redox-responsive drug delivery systems react to glutathione concentration gradients that are significantly elevated inside cancer cells compared to extracellular environments. Disulfide linkages and other redox-sensitive bonds are cleaved selectively in the intracellular reducing environment.
Glutathione gradient activationPhoto-Responsive Platforms
Photo-responsive drug release platforms are activated by near-infrared or UV light, offering spatiotemporal precision in drug delivery. These systems incorporate photosensitive moieties — such as azobenzene or spiropyran — that undergo structural changes upon irradiation to release encapsulated therapeutics.
NIR / UV light activationIPC Classification Coverage Across Stimuli Modalities
Understanding how stimuli-responsive drug delivery innovations are classified across EPO and USPTO IPC codes is essential for comprehensive landscape analysis.
Key IPC Classes for Stimuli-Responsive Drug Delivery
Four IPC classification codes span the stimuli-responsive drug delivery research space, covering preparations, therapeutic activity, chemical processes, and macromolecular compounds.
Research Source Coverage by Database Type
Comprehensive landscape analysis requires data from both patent databases (USPTO, EPO, WIPO) and academic literature sources (PubMed, Scopus, Web of Science).
What a Complete Landscape Report Requires
Producing a fully evidenced, publication-quality landscape report on stimuli-responsive drug release materials requires four categories of structured data. First, patent records from USPTO, EPO, or WIPO covering IPC classes A61K, A61P, B01J, and C08F relevant to responsive drug delivery must be retrieved and analysed.
Second, literature sources from PubMed, Scopus, or Web of Science covering pH-responsive, thermo-responsive, redox-responsive, and photo-responsive drug carriers must be systematically included. Third, assignee metadata — including company names, university affiliations, and inventor records — is essential for competitive intelligence. Fourth, publication URLs are required for every inline citation to ensure editorial integrity.
PatSnap Eureka consolidates all four data categories into a single AI-powered analytics platform, enabling researchers to run comprehensive landscape queries across over 2 billion data points from 120+ countries without switching between databases.
- Patent records: USPTO, EPO, WIPO — IPC classes A61K, A61P, B01J, C08F
- Literature sources: PubMed, Scopus, Web of Science
- Assignee metadata: company names, university affiliations, inventor records
- Publication URLs for every inline citation
What a Full Landscape Analysis Delivers
Once populated with patent and literature records, a thematic analysis of stimuli-responsive drug release materials covers these critical intelligence domains.
Material Approaches by Modality
A thematic analysis covering material approaches — polymeric nanoparticles, hydrogels, liposomes, mesoporous silica — organised by stimuli modality: pH, thermo, redox, and photo-responsive systems.
Application Domain Mapping
Identification of primary application domains across oncology, gene therapy, anti-infective delivery, and personalised medicine — mapped to assignee organisations and IPC subclasses.
From Data Query to Landscape Report
A structured three-stage process transforms raw patent and literature queries into actionable stimuli-responsive drug delivery intelligence.
Need assignee data and inventor records for your research?
PatSnap Eureka surfaces assignee metadata, filing trends, and inventor networks across all major patent offices.
Stimuli-Responsive Drug Release Materials — key questions answered
Stimuli-responsive drug release materials are smart carrier systems that release therapeutic payloads in response to specific physiological or external triggers — including pH shifts, temperature changes, redox gradients, or light exposure. They are classified under IPC codes A61K, A61P, B01J, and C08F in patent databases.
The 2026 landscape covers four primary stimuli modalities: pH-responsive carriers that exploit tumour microenvironment acidity, thermo-responsive systems that release drug payloads above physiological temperature thresholds, redox-responsive materials that react to glutathione gradients inside cancer cells, and photo-responsive platforms activated by near-infrared or UV light.
The most relevant patent databases for stimuli-responsive drug delivery research are USPTO, EPO, and WIPO. Key IPC classification codes to search include A61K (preparations for medical purposes), A61P (therapeutic activity), B01J (chemical or physical processes), and C08F (macromolecular compounds).
Key literature sources for stimuli-responsive drug delivery research include PubMed, Scopus, and Web of Science. These databases index peer-reviewed publications on pH-responsive, thermo-responsive, redox-responsive, and photo-responsive drug carriers across chemistry, materials science, and pharmaceutical engineering disciplines.
PatSnap Eureka provides AI-powered patent and literature search across over 2 billion data points from 120+ countries. Researchers can query IPC classes relevant to responsive drug delivery, identify key assignees and inventors, map technology trends, and generate landscape reports — all from a single platform used by 18,000+ innovators worldwide.
A complete landscape report on stimuli-responsive drug release materials requires patent records from USPTO, EPO, or WIPO covering IPC classes A61K, A61P, B01J, and C08F; literature sources from PubMed, Scopus, or Web of Science; assignee metadata including company names and university affiliations; and publication URLs for every inline citation.
Still have questions? Let PatSnap Eureka answer them for you.
Ask PatSnap Eureka →Run the Full Stimuli-Responsive Drug Delivery Landscape Analysis
Join 18,000+ innovators already using PatSnap Eureka to accelerate their R&D across patent and literature intelligence.
References
- WIPO — World Intellectual Property Organization — International patent classification system (IPC) covering A61K, A61P, B01J, C08F codes used for stimuli-responsive drug delivery research.
- USPTO — United States Patent and Trademark Office — Primary US patent database for stimuli-responsive drug delivery system filings.
- EPO — European Patent Office — European patent database and Espacenet search platform for responsive drug carrier patents.
- PubMed — National Library of Medicine — Primary literature database for peer-reviewed publications on pH-responsive, thermo-responsive, redox-responsive, and photo-responsive drug carriers.
- PatSnap Analytics — IP Analytics Platform — AI-powered patent landscape analysis and competitive intelligence platform covering 2B+ data points from 120+ countries.
- PatSnap Life Sciences Solutions — Dedicated patent and literature intelligence tools for pharmaceutical, biotech, and drug delivery research teams.
All data and statistics on this page are sourced from the references above and from PatSnap's proprietary innovation intelligence platform.
PatSnap Eureka searches patents and research to answer instantly.